Centre Hospitalier Universitaire, Amiens
chu-amiens.frTotal trials
568
Active
170
Phase 3
47
Total enrollment
415,557
Read this sponsor's pipeline like an analyst.
Generate a written report: strategic focus, priority programs, pipeline shape, recent terminations and momentum, and the trials worth watching in the next 12 months.
~15-30 sec · cached for 24h
Pipeline matrix
Showing 40 of 64 active programs · click any cell for trials
| Intervention | Early Phase 1 | Phase 1 | Phase 2 | Phase 3 | Phase 4 | N/A | Total |
|---|---|---|---|---|---|---|---|
| blood test | — | — | — | — | 3 | ||
| blood sample | — | — | — | — | 15 | ||
| ketoprofen | — | — | — | — | 2 | ||
| Antibiotics | — | — | — | — | 2 | ||
| ropivacaine | — | — | — | — | 3 | ||
| Landiolol | — | — | — | — | — | 1 | |
| noradrenaline and vascular filling | — | — | — | — | — | 1 | |
| caspofungin antifungal therapy | — | — | — | — | — | 1 | |
| lidocaine treatment | — | — | — | — | — | 1 | |
| serratus plane block treatment | — | — | — | — | — | 1 | |
| AZA | — | — | — | — | — | 1 | |
| MTX | — | — | — | — | — | 1 | |
| pain management | — | — | — | — | — | 1 | |
| Nicotinamide treatment | — | — | — | — | — | 1 | |
| Procedure/Standard care | — | — | — | — | — | 1 | |
| Lidocaine | — | — | — | — | — | 1 | |
| Clarithromycin 1000 MG | — | — | — | — | — | 1 | |
| Azithromycin 250 mg | — | — | — | — | — | 1 | |
| Rifampicin | — | — | — | — | — | 1 | |
| Ethambutol | — | — | — | — | — | 1 | |
| hydrocortisone plus fludrocortisone | — | — | — | — | — | 1 | |
| parasternal block | — | — | — | — | — | 1 | |
| Standard pain management | — | — | — | — | — | 1 | |
| GCP intratumoral catheter | — | — | — | — | — | 1 | |
| inhaled type I interferon | — | — | — | — | — | 1 | |
| WFI water nebulization | — | — | — | — | — | 1 | |
| Arikayce | — | — | — | — | — | 1 | |
| standard treatment | — | — | — | — | — | 1 | |
| Sirolimus | — | — | — | — | — | 1 | |
| blood withdrawal | — | — | — | — | — | 4 | |
| blood sampling | — | — | — | — | — | 3 | |
| blood samples | — | — | — | — | — | 3 | |
| Blood | — | — | — | — | — | 2 | |
| identification of genetic factors | — | — | — | — | — | 1 | |
| blood redrawal | — | — | — | — | — | 1 | |
| glucose measurement | — | — | — | — | — | 1 | |
| lactacte measurement | — | — | — | — | — | 1 | |
| pyruvate measurement | — | — | — | — | — | 1 | |
| glycerol measurement | — | — | — | — | — | 1 | |
| ofloxacin | — | — | — | — | — | 1 |
24 more active programs hidden
Next readouts
- 2022-04-01
- 2023-06-16
- 2023-11-22
- 2024-10-04
- 2024-12
- 2024-12-31
- 2025-04-01
- 2025-06
- 2025-06
- 2025-07
Top conditions
- Septic Shock10
- Covid1910
- Surgery9
- Stroke9
- Cardiac Surgery8
- Alzheimer Disease8
- Thoracic Surgery8
- Acute Kidney Injury7
Frequently asked questions about Centre Hospitalier Universitaire, Amiens
- How many clinical trials does Centre Hospitalier Universitaire, Amiens have on ClinicalTrials.gov?
- Centre Hospitalier Universitaire, Amiens is listed as the lead sponsor on 568 clinical trials in ClinicalTrials.gov, 170 of which are currently active (recruiting, enrolling, or ongoing).
- How many of Centre Hospitalier Universitaire, Amiens's trials are in Phase 3?
- 47 of Centre Hospitalier Universitaire, Amiens's trials are in Phase 3, spread across 64 active drug programs.
- What therapeutic areas does Centre Hospitalier Universitaire, Amiens focus on?
- Centre Hospitalier Universitaire, Amiens's most-studied conditions on ClinicalTrials.gov are Septic Shock, Covid19, Surgery, Stroke, Cardiac Surgery.
- When are Centre Hospitalier Universitaire, Amiens's next clinical trial readouts?
- Centre Hospitalier Universitaire, Amiens has 10 upcoming primary-completion readouts tracked here; the soonest is “Predictive Factors of Good Pulmonary Penetration of Antibiotics : AntiBiotics Dosage in Broncho-Alveolar Lavage”, expected around 2022-04-01.